Co-existence of heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura in a postoperative cardiac surgery patient

American Journal of Hematology

Volumn 80, Issue 4, 2005, Pages 288-291

  Benke, Stanley ^a,c   Moltzan, Catherine ^a,b,c,d  

^a Pediatric Hematology/Oncology   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c CANCERCARE MANITOBA   (Canada)

^d ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Cardiac surgery; Heparin induced; Post operative; Pulmonary embolism; Thrombocytopenia; Thrombotic thrombocytopenic purpura

Indexed keywords

CREATININE; DANAPAROID; HEMOGLOBIN; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; WARFARIN;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANTICOAGULANTS; CORONARY ARTERY BYPASS; HEPARIN; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; THROMBOCYTOPENIA;

EID: 28544447813     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20436     Document Type: Article

References (24)

1. Trossaert M, Gaillard A, Commin PL, Amiral J, Vissac AM, Fressinau E. High incidence of anti-heparin/plalelet factor 4 antibodies after cardiopulmonary bypass surgery. Br J Haematol 1998;101(4):653-655.
2. Warkentin TE, Sheppard JI, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000;96:1703-1708.
3. Bauer TL, Arepally G, Konkle BA, et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997;95:1242-1246.
4. Konkle BA, Bauer TL, Arepally G, et al. Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery. Ann Thorac Surg 2001;71:1920-1924.
5. Francis JL, Palmer GP III, Moroose R, Drexler A. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Ann Thorac Surg 2003;75:17-22.
6. Pouplard C. May MA, Regina S, Maakaroun A, Fusciardi J, Gruel Y. Changes in the platelet count after cardiopulmonary bypass can efficiently predict the development of pathogenic heparin-dependent antibodies Blood 2002;100:16a-17a.
7. Walls JT, Curtis JJ, Silver D, Boley TM, Schmaltz RA, Nawarawong W. Heparin-induced thrombocylopenia in open heart surgical patients: sequelae of late recognition. Ann Thorac Surg 1992;53:787-791.
8. Singer RL, Mannion JD, Bauer TL, Armenti FR, Edie RN. Complications from heparin-induced thrombqcytopenia in patients undergoing cardiopulmonary bypass. Chest. 1993;104: 1436-1440.
9. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996;101:502-507.
10. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332: 1330-1335.
11. Betrosian AP, Theodossiades G, Lambroulis G, et al. Heparin-induced thrombocytopenia with pulmonary embolism and disseminated intravascular coagulation associated with low molecular-weight heparin. Am J Med Sci 2003;325:45-47.
12. Ridolfi RL, Bell WR. Thrombotic thrombocylopenic purpura: report of 25 cases and review of the literature. Medicine (Baltimore) 1981;60:413-428.
13. Moake J. Thrombotic microangiopathies. N Engl J Med 2002;347: 589-599.
14. Naqvi TA, Baumann MA, Chang JC. Postoperative thrombotic thrombocytopenic purpura: a review. Int J Clin Pract 2004;58: 169-172.
15. Pavlosky M, Weinstein R. Thrombotic thrombocytopenic purpura following coronary artery bypass graft surgery: prospective observations of an emerging syndrome. J Clin Apheresis 1997;12: 159-164.
16. Visentin GP, Ford SE, Scott JP, et al. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994;93:81-88.
17. Greinacher A, Potzsch B, Amiral J, et al. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994;71:247-251.
18. Newman PM, Chong BH. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood 2000;96:182-187.
19. Lillo-Le Louet A, Boutouyrie P, Alhene-Gelas M, et al. Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost 2004;2(11):1882-1888.
20. Tsai HM, Lian ECY. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-1594.
21. Bianchi V, Robles R, Alberio E, Furlan M, Lämmle B. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood 2002;100:710-713.
22. Bernardo A, Ball C, Nolasco E, Moake JF, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under now. Blood 2004;104(1):100-106.
23. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991;325: 393-397.
24. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: clinical experience in 108 patients. N Engl J Med 1991;325:398-403.